ArticleJournal of the International AIDS Society2019

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort.

Annalisa Mondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.